Newsletter | February 13, 2025

02.13.25 -- Life Biosciences' Successful Partnership With Forge Biologics

SPONSOR

Are you attending World ADC London this year? On March 4th, don't miss our presentation on "Technical Excellence in Development and Manufacturing of Bioconjugates". Visit booth #10 to meet our team and discover how we can accelerate your ADC, bioconjugate, or small molecule conjugate program. Request a meeting to discuss your needs with our experts and discover how we can support you with our 15+ years of experience and leading expertise in contract development and manufacturing.

FOCUS ON OUTSOURCING

Life Biosciences' Successful Partnership With Forge Biologics

Life Biosciences' Jerry McLaughlin and Forge Biologics' John Maslowski discuss their companies’ partnership, Life’s pipeline, and Columbus’ biotech hub.

How-To Master Tech Transfer: Strategies To Sidestep Common Pitfalls

Ensure a smooth and efficient technology transfer by following key strategies and avoiding common pitfalls to streamline your process and achieve consistent, error-free results.

Effective Technology Transfer For Mammalian Derived Biopharmaceuticals

Gain the knowledge and tools necessary to facilitate successful technology transfer and accelerate the translation of your projects from bench to market.

Tech Transfer At Risk: The Imperative For Digital Maturity, Modernization

Tech transfer is critical for biopharmaceutical production, but outdated tools can hinder the process. Discover how digital maturity can streamline operations, reduce risks, and accelerate time to market.

From Nanoformed Powder To 3D Printable Ink

3D printing in pharmaceutics is advancing to offer innovative drug delivery applications. Explore the possibilities of forming stable suspension in printing ink from nanoformed materials.

Growing A Sustainability Culture Across An Expanding CDMO Network

Peter Skals, Head of Global Sustainability, shares how the company is integrating its climate and ESG strategy while simultaneously expanding its CDMO network and reducing its CO2 footprint.

Process Optimization For mAb Commercial Manufacturing

Strategically optimize your upstream and downstream processes and decrease the timeline from optimization to commercial manufacturing.

Downstream Strategies To Accelerate Preclinical Development Timelines

As recombinant protein-based products accelerate toward IND, reliable process development methods are critical to meet demand. Review case studies to learn how expedited timelines can be achieved.

SPONSOR

Webinar: Bioprocess Optimization – Leveraging Functional DOE with Time-based Insights

While traditional Design of Experiments (DOE) methods help identify critical quality attributes and process parameters, they often focus on single-value outcomes, which narrowed focus overlooks the dynamic, time-dependent nature of bioprocesses. Join Samsung as they explore how functional DOE addresses this gap by leveraging time-based data to predict the evolution of key process parameters and uncover complex interactions, providing deeper insights for optimizing bioprocesses. Learn more.

OUTSOURCING SOLUTIONS

Simtra Brand Anthem Video - Simtra BioPharma Solutions

Our Approach: Viral Vectors Made Accessible - VintaBio

Surfactant Analysis Services - Lonza

AAV cGMP Manufacturing Located In San Sebastian, Spain - Viralgen

Large Molecule Biologics Made With Intelligent Collaboration - Pfizer CentreOne

Viral Vaccine Lot Release Package - WuXi Advanced Therapies

NEW PODCAST EPISODE

BoB@JPM: Peter Anastasiou, Capsida Biotherapeutics

From the JP Morgan Healthcare Conference in San Francisco, Peter Anastasiou, CEO of Capsida Biotherapeutics, joins the Business of Biotech to discuss his journey from big pharma to biotech and the challenges he faces on the leading edge of first-generation gene therapies. From mastering in-house manufacturing to forging strategic partnerships, Capsida aims to redefine genetic medicine. Listen now!

Connect With Bioprocess Online: